Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,324 papers from all fields of science
Search
Sign In
Create Free Account
saxagliptin 5 MG Oral Tablet [Onglyza]
Known as:
Onglyza (as saxagliptin hydrochloride 5.58 MG) 5 MG Oral Tablet
, onglyza 5 MG Oral Tablet
, saxagliptin hydrochloride 5 mg ORAL TABLET, FILM COATED [ONGLYZA]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Croscarmellose Sodium
Lactose Monohydrate
Magnesium stearate
Onglyza
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Arthralgies et arthrites d’origine médicamenteuses, rares ou émergentes
J. Berthelot
,
G. Veyrac
Revue du Rhumatisme Monographies
2018
Corpus ID: 81732651
2015
2015
Of the Big Daddy, the Underdog, the Mother Hen, and the Scapegoats: Balancing Pharmaceutical Innovation and Access to Healthcare in the Enforcement of Compulsory Patent Licensing in India, its…
M. Chopra
2015
Corpus ID: 169500374
2014
2014
Saxagliptin: a guide to its use in type 2 diabetes mellitus
K. Lyseng-Williamson
,
Lily P. H. Yang
2014
Corpus ID: 71371922
Oral saxagliptin (Onglyza®), a potent, selective dipeptidyl pepitase-4 inhibitor, is a useful option to improve glycaemic control…
Expand
2012
2012
Effect of saxagliptin on the pharmacokinetics of the active components of Ortho‐Cyclen®, a combined oral contraceptive containing ethinyl estradiol and norgestimate, in healthy women
V. Upreti
,
C. B. Hsiang
,
L. Li
,
X. Xu
,
F. LaCreta
,
D. Boulton
Diabetes, obesity and metabolism
2012
Corpus ID: 8042901
Saxagliptin (Onglyza™) is a dipeptidyl peptidase‐4 (DPP4) inhibitor for treating type 2 diabetes mellitus. This open‐label…
Expand
2010
2010
La saxagliptine (Onglyza®) - un nouvel inhibiteur de la DPP-4 pour le traitement oral du diabète de type 2
M. Hermans
2010
Corpus ID: 78587651
• L'enzyme DPP-4 degrade physiologiquement les incretines GLP-1 et GIP. • La saxagliptine (Onglyza ® ) est un inhibiteur oral de…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE